DK1140933T3 - Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater - Google Patents

Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater

Info

Publication number
DK1140933T3
DK1140933T3 DK99966299T DK99966299T DK1140933T3 DK 1140933 T3 DK1140933 T3 DK 1140933T3 DK 99966299 T DK99966299 T DK 99966299T DK 99966299 T DK99966299 T DK 99966299T DK 1140933 T3 DK1140933 T3 DK 1140933T3
Authority
DK
Denmark
Prior art keywords
preparation
adenosine derivatives
substituted
deaza
substituted deaza
Prior art date
Application number
DK99966299T
Other languages
Danish (da)
English (en)
Inventor
Luc Grondard
Matthew R Powers
Michael K O'brien
Adam W Sledeski
Tory H Powner
Ching T Tsuei
Patrick Leon
Gregory G Kubiak
Laurence Pailleres-Hubert
Benoit Viguier
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK1140933T3 publication Critical patent/DK1140933T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK99966299T 1998-12-31 1999-12-15 Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater DK1140933T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11448698P 1998-12-31 1998-12-31
US11602899P 1999-01-15 1999-01-15
EP99966299A EP1140933B1 (en) 1998-12-31 1999-12-15 Process for preparing n6-substituted deaza-adenosine derivatives

Publications (1)

Publication Number Publication Date
DK1140933T3 true DK1140933T3 (da) 2004-12-20

Family

ID=26812247

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99966299T DK1140933T3 (da) 1998-12-31 1999-12-15 Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater

Country Status (16)

Country Link
US (1) US6429315B1 (pt)
EP (1) EP1140933B1 (pt)
JP (1) JP2002534430A (pt)
KR (1) KR20010089751A (pt)
CN (1) CN1383427A (pt)
AT (1) ATE275565T1 (pt)
AU (1) AU2187100A (pt)
BR (1) BR9917000A (pt)
CA (1) CA2358962A1 (pt)
DE (1) DE69920045T2 (pt)
DK (1) DK1140933T3 (pt)
ES (1) ES2228163T3 (pt)
HK (1) HK1040239A1 (pt)
PT (1) PT1140933E (pt)
SI (1) SI1140933T1 (pt)
WO (1) WO2000040584A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002534430A (ja) 1998-12-31 2002-10-15 アベンティス・ファーマスーティカルズ・プロダクツ・インコーポレイテツド N6−置換デアザアデノシン誘導体類の製造法
GT200500281A (es) * 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0500785D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
GB0607950D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607944D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607953D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
US8258141B2 (en) 2006-04-21 2012-09-04 Novartis Ag Organic compounds
GB0607948D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
EP1889846A1 (en) 2006-07-13 2008-02-20 Novartis AG Purine derivatives as A2a agonists
EP1903044A1 (en) * 2006-09-14 2008-03-26 Novartis AG Adenosine Derivatives as A2A Receptor Agonists
KR20090087054A (ko) * 2006-11-10 2009-08-14 노파르티스 아게 시클로펜텐 디올 모노아세테이트 유도체

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0550631T3 (da) 1990-09-25 1997-01-20 Rhone Poulenc Rorer Int Forbindelser med blodtrykssænkende virkning og virkning mod iskæmi
US5652366A (en) 1990-09-25 1997-07-29 Rhone-Poulenc Rorer Pharmaceuticals Inc. DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
US5561134A (en) 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US5545769A (en) 1994-09-29 1996-08-13 E. I. Du Pont De Nemours And Company Process for the manufacture of selected halogenated hydrocarbons containing fluorine and hydrogen and compositions provided therein
US5684159A (en) 1995-05-30 1997-11-04 Rhone-Poulenc Rorer S.A. L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds
FR2734822B1 (fr) 1995-05-30 1997-07-04 Rhone Poulenc Rorer Sa Nouveaux derives du 2-azabicyclo(2.2.1)heptane, leur preparation et leur application
EA000884B1 (ru) 1996-01-02 2000-06-26 Рон-Пуленк Рорер Фармасьютикалз Инк. Способ получения 2,4-дигидроксипиридина и 2,4-дигидрокси-3-нитропиридина
UA51716C2 (uk) * 1996-07-08 2002-12-16 Авентіс Фармасьютікалз Продактс Інк. Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування
SK26999A3 (en) 1996-09-12 1999-10-08 Rhone Poulenc Rorer Pharma Stereospecific preparation of chiral 1-aryl- and 1-heteroaryl-2- -substituted ethyl-2-amines
JP2001506626A (ja) 1996-12-11 2001-05-22 アヴェンティス ファーマシューティカルズ プロダクツ インコーポレイテッド [1S−[1a,2b,3b,4a(S*)]]−4−[7−[[1−(3−クロロ−2−チエニル)メチル]プロピル]アミノ]−3H−イミダゾ[4,5−b]ピリジン−3−イル]−N−エチル−2,3−ジヒドロキシシクロペンタンカルボキサミドの調製
JP2002534430A (ja) 1998-12-31 2002-10-15 アベンティス・ファーマスーティカルズ・プロダクツ・インコーポレイテツド N6−置換デアザアデノシン誘導体類の製造法

Also Published As

Publication number Publication date
PT1140933E (pt) 2004-12-31
AU2187100A (en) 2000-07-24
SI1140933T1 (en) 2005-02-28
WO2000040584A2 (en) 2000-07-13
CA2358962A1 (en) 2000-07-13
ES2228163T3 (es) 2005-04-01
DE69920045D1 (de) 2004-10-14
US6429315B1 (en) 2002-08-06
KR20010089751A (ko) 2001-10-08
JP2002534430A (ja) 2002-10-15
EP1140933B1 (en) 2004-09-08
CN1383427A (zh) 2002-12-04
ATE275565T1 (de) 2004-09-15
BR9917000A (pt) 2001-12-11
HK1040239A1 (en) 2002-05-31
WO2000040584A3 (en) 2000-11-02
EP1140933A2 (en) 2001-10-10
DE69920045T2 (de) 2005-09-29

Similar Documents

Publication Publication Date Title
PT1040108E (pt) Derivados de orto-antranilamida como anticoagulantes
LT2001061A (en) Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
DK1040107T3 (da) 6-O-alkyl-derivater af erythronolid B
DK1083903T3 (da) Brobundne indenopyrrolocarbazoler
DK1015466T3 (da) Derivater af 9-hydrazon og 9-azinerythromycin og en fremgangsmåde til fremstilling af samme
DK1140933T3 (da) Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater
DK1068209T3 (da) Fremgangsmåde til fremstilling af purinderivater og deres mellemprodukter
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DK1307436T3 (da) Fremgangsmåde til fremstilling af baccatin III-derivater
DE69703115T2 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
YU51401A (sh) Postupak za dobijanje n6-supstituisanih derivata deaza-adenozima
DK1001929T3 (da) Fremgangsmåde til fremstilling af 3-cyano-2,4-dihalogen-5-flour-benzoesyrer
CY1109583T1 (el) Κυτοκινες θηλαστικων, αντιστοιχα αντιδραστηρια
DK0981950T3 (da) Fremgangsm,åde til formering af phyllocactus
DK0817784T3 (da) Fremgangsmåde til syntese af nucleosidanaloger
TR200101084T2 (tr) Antineoplastik maddeler üretmeye mahsus stereoselektif yöntem
DK0961770T3 (da) Fremgangsmåder til fremstilling af 3-cyanopyridin ud fra 2-methyl-1,5-pentandiamin
EA200000705A1 (ru) Промежуточные соединения и способ синтеза 17-замещенных 16.бета.-арилокси 4-азастероидов
DK1104415T3 (da) Fremgangsmåde til fremstilling af 1,3-oxathiolan-nukleosider
ECSP003511A (es) Procedimiento para preparar derivados de 10,11-metanobenzosuberano